Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?

European Journal of Surgical Oncology

Volumn 39, Issue 8, 2013, Pages 880-886

  Tausch, C ^a   Baege, A ^a,b   Dietrich, D ^c   Vergin, I ^a   Heuer, H ^a,b   Heusler, R Haldemann ^d   Rageth, C ^a  

^a Brust Zentrum Zurich   (Switzerland)

^b UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^c SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

^d Institute of Radiology and Nuclear Medicine   (Switzerland)

Author keywords

Axillary reverse mapping; Breast cancer; Lymphedema; Node positive

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; AXILLARY REVERSE MAPPING; BREAST CANCER; FEMALE; FOLLOW UP; HUMAN; ISOTOPE LABELING; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; LYMPHEDEMA; MAJOR CLINICAL STUDY; ONCOLOGICAL PROCEDURE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AXILLARY REVERSE MAPPING; BREAST CANCER; LYMPHEDEMA; NODE POSITIVE;

ADULT; AGED; AGED, 80 AND OVER; ARM; AXILLA; BREAST NEOPLASMS; COHORT STUDIES; COLORING AGENTS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC VESSELS; LYMPHEDEMA; MASTECTOMY; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84879839944     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.05.009     Document Type: Article

References (34)

1. P.L. Fitzgibbons, D.L. Page, and D. Weaver Prognostic factors in breast cancer: college of American pathologists consensus statement Arch Pathol Lab Med 124 1999 966 978
2. V. Vinh-Hung, T. Burzykowski, and G. Cserni Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer Int Oncol 22 2003 697 704
3. T. Schulze, J. Mucke, and J. Markwardt Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection J Surg Oncol 93 2006 109 119
4. W.A. Woodward, E.A. Strom, and S.L. Tucker Changes in the 2003 American Joint Committee on cancer staging for breast cancer dramatically affect stage-specific survival J Clin Oncol 21 2003 3244 3338
5. G.H. Lyman, A.E. Giuliano, and M.R. Somerfield American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 30 2005 7703 7720
6. J.J. Chen, and J. Wu Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: with or without axillary lymph node dissection J Crit Rev Oncol Hematol 79 3 2011 293 301
7. T. Ashikaga, D.N. Krag, and S.R.J. Land Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection Surg Oncol 102 2 2010 111 118
8. R.E. Mansel, L. Fallowfield, and M. Kissin Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 9 2006 599 609
9. I. Langer, U. Guller, and C.T. Viehl Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study Ann Surg Oncol 16 12 2009 3366 3374
10. A.M. Naik, J. Fey, and M. Gemignani The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures Ann Surg 240 3 2004 462 468
11. R.F. Hwang, A.M. Gonzalez-Angulo, and M. Yi Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection Cancer 110 4 2007 723 730
12. A.E. Giuliano, L. McCall, and P. Beitsch Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 3 2010 426 432
13. A.E. Giuliano, K.K. Hunt, and K.V. Ballman Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 6 2011 569 575
14. A. Goldhirsch, W.C. Wood, A.S. Coates, R.D. Gelber, B. Thürlimann, and H.J. Senn Panel members. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2011 Ann Oncol 22 8 2011 1736 1747
15. C. Nos, B. Lesieur, K.B. Clough, and F. Lecuru Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection Ann Surg Oncol 14 9 2007 2490 2496
16. M. Thompson, S. Korourian, and R. Henry-Tillman Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation Ann Surg Oncol 14 6 2007 1890 1895
17. R. Ponzone, N.T. Cont, and F. Maggiorotto Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer J Clin Oncol 27 33 2009 5547 5551
18. C. Boneti, S. Korourian, and Z. Diaz Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy Am J Surg 198 2009 482 487
19. F. Casabona, S. Bogliolo, M.V. Menada, P. Sala, G. Villa, and S. Ferrero Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients Ann Surg Oncol 16 2009 2459 2466
20. H. Deng, L. Chen, and W. Jia Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients J Cancer Res Clin Oncol 137 12 2011 1869 1874
21. J.W. Han, Y.J. Seo, and J.E. Choi The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer J Breast Cancer 15 1 2012 91 97
22. I. Bedrosian, G.V. Babiera, and E.A. Mittendorf A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients Cancer 116 11 2010 2543 2548
23. M. Noguchi, M. Noguchi, and Y. Nakano Axillary reverse mapping using a fluorescence imaging system in breast cancer J Surg Oncol 105 3 2012 229 234
24. C. Nos, G. Kaufmann, and K.B. Clough Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection Ann Surg Oncol 15 9 2008 2550 2555
25. R.J. Damstra, E.J. Glazenburg, and W.C.J. Hop Validation of the inverse water volumetry method: a new gold standard for arm volume measurements Breast Cancer Res Treat 99 2006 267 273
26. K.A. Meeske, J. Sullivan-Halley, and A.W. Smith Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women Breast Cancer Res Treat 113 2 2009 383 391
27. S. Vignes, M. Arrault, and A. Dupuy Factors associated with increased breast cancer-related lymphedema volume Acta Oncol 46 8 2007 1138 1142
28. L.K. Helyer, M. Varnic, L.W. Le, W. Leong, and D. McCready Obesity is a risk factor for developing lymphedema in breast cancer patients Breast J 16 1 2010 48 54
29. D. Pavlista, and O. Eliska Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla - a lesson from the past - contribution to the concept of axillary reverse mapping Eur J Surg Oncol 38 2009 390 394
30. P.C. Sappey Anatomie, Physiologie, Pathologie des vaisseaux lymphatiques 1874 Adrien Delahaye Paris
31. G. Delamere, P. Poirier, and B. Cuneo The lymphatics P.P. Charpy, A trearise of human anatomy 1903 Archibald Constable Westminster
32. H. Rouviere Anatomie des lymphatiques de l'homme 1932 Masson et Cie Edit Paris
33. R.T. Turner-Warwick The lymphatics of the breast Br J Surg 46 1959 574 582
34. J. Sobotta Atlas d'Anatomie Humaine 1977 Urban Schwarzenberg, München-Wien-Baltimore Paris Maloine